# Arthur J. Gallagher & Co.: financial statements, quarterly

AJG · NYSE · CIK 354190 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ajg.md) · [Financials](/companies/ajg/financials.md) · [Filings](/companies/ajg/filings.md) · [Insiders](/companies/ajg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ajg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,492](/filings/0000950170-24-118320.md) | [2,432 d](/filings/0001628280-26-008662.md) | [3,257](/filings/0000950170-25-062859.md) | [2,775](/filings/0000354190-25-000011.md) | [2,807](/filings/0001628280-25-050734.md) | [2,716 d](/filings/0001628280-26-008662.md) | [3,727](/filings/0001628280-26-031592.md) | [3,222](/filings/0001628280-26-053489.md) | [3,366](/filings/0001628280-25-050734.md) | [3,628 d](/filings/0001628280-26-008662.md) | [4,758](/filings/0001628280-26-031592.md) | [4,003](/filings/0001628280-26-053489.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [72.8](/filings/0000950170-24-118320.md) | [78.5 d](/filings/0001628280-26-008662.md) | [92.2](/filings/0000950170-25-062859.md) | [94.3](/filings/0000354190-25-000011.md) | [92.9](/filings/0001628280-25-050734.md) | [102 d](/filings/0001628280-26-008662.md) | [158](/filings/0001628280-26-031592.md) | [158](/filings/0001628280-26-053489.md) | [161](/filings/0001628280-25-050734.md) | [161 d](/filings/0001628280-26-008662.md) | [158](/filings/0001628280-26-031592.md) | [168](/filings/0001628280-26-053489.md) |
| Income tax | $m | [80.9](/filings/0000950170-24-118320.md) | [(42.7) d](/filings/0001628280-26-008662.md) | [160](/filings/0000950170-25-062859.md) | [80.2](/filings/0000354190-25-000011.md) | [89.2](/filings/0001628280-25-050734.md) | [74.6 d](/filings/0001628280-26-008662.md) | [164](/filings/0001628280-26-031592.md) | [105](/filings/0001628280-26-053489.md) | [73.3](/filings/0001628280-25-050734.md) | [25.7 d](/filings/0001628280-26-008662.md) | [220](/filings/0001628280-26-031592.md) | [90.0](/filings/0001628280-26-053489.md) |
| Net income | $m | [281](/filings/0000950170-24-118320.md) | [(31.7) d](/filings/0001628280-26-008662.md) | [608](/filings/0000950170-25-062859.md) | [283](/filings/0000354190-25-000011.md) | [313](/filings/0001628280-25-050734.md) | [259 d](/filings/0001628280-26-008662.md) | [704](/filings/0001628280-26-031592.md) | [368](/filings/0001628280-26-053489.md) | [273](/filings/0001628280-25-050734.md) | [151 d](/filings/0001628280-26-008662.md) | [822](/filings/0001628280-26-031592.md) | [324](/filings/0001628280-26-053489.md) |
| Diluted EPS | $ per share | [1.28](/filings/0000950170-24-118320.md) | not reported | [2.74](/filings/0000950170-25-062859.md) | [1.27](/filings/0000354190-25-000011.md) | [1.39](/filings/0001628280-25-050734.md) | not reported | [2.72](/filings/0001628280-26-031592.md) | [1.40](/filings/0001628280-26-053489.md) | [1.04](/filings/0001628280-25-050734.md) | not reported | [3.16](/filings/0001628280-26-031592.md) | [1.25](/filings/0001628280-26-053489.md) |
| Basic EPS | $ per share | [1.30](/filings/0000950170-24-118320.md) | not reported | [2.80](/filings/0000950170-25-062859.md) | [1.30](/filings/0000354190-25-000011.md) | [1.43](/filings/0001628280-25-050734.md) | not reported | [2.76](/filings/0001628280-26-031592.md) | [1.43](/filings/0001628280-26-053489.md) | [1.06](/filings/0001628280-25-050734.md) | not reported | [3.20](/filings/0001628280-26-031592.md) | [1.26](/filings/0001628280-26-053489.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0000950170-23-056014.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [35.9](/filings/0000950170-23-056014.md) | [32.1](/filings/0000950170-25-021775.md) | [41.5](/filings/0000950170-24-050950.md) | [43.3](/filings/0000950170-24-086937.md) | [37.3](/filings/0000950170-24-118320.md) | [44.1](/filings/0001628280-26-008662.md) | [53.4](/filings/0000950170-25-062859.md) | [57.8](/filings/0000354190-25-000011.md) | [43.0](/filings/0001628280-25-050734.md) | [34.4](/filings/0001628280-26-053489.md) | [42.0](/filings/0001628280-26-031592.md) | [45.5](/filings/0001628280-26-053489.md) |
| Total assets | $bn | [53.2](/filings/0000950170-24-118320.md) | [51.6](/filings/0001628280-26-008662.md) | [61.0](/filings/0000950170-25-062859.md) | [63.0](/filings/0000354190-25-000011.md) | [57.2](/filings/0001628280-25-050734.md) | [64.3](/filings/0001628280-26-008662.md) | [74.1](/filings/0001628280-26-031592.md) | [80.1](/filings/0001628280-26-053489.md) | [79.1](/filings/0001628280-25-050734.md) | [70.7](/filings/0001628280-26-053489.md) | [78.3](/filings/0001628280-26-031592.md) | [81.8](/filings/0001628280-26-053489.md) |
| Current liabilities | $bn | [34.5](/filings/0000950170-23-056014.md) | [31.1](/filings/0000950170-25-021775.md) | [39.6](/filings/0000950170-24-050950.md) | [41.6](/filings/0000950170-24-086937.md) | [35.2](/filings/0000950170-24-118320.md) | [29.3](/filings/0001628280-26-008662.md) | [37.0](/filings/0000950170-25-062859.md) | [42.5](/filings/0000354190-25-000011.md) | [40.8](/filings/0001628280-25-050734.md) | [32.5](/filings/0001628280-26-053489.md) | [39.5](/filings/0001628280-26-031592.md) | [43.2](/filings/0001628280-26-053489.md) |
| Total liabilities | $bn | [42.7](/filings/0000950170-23-056014.md) | [40.8](/filings/0000950170-25-021775.md) | [49.6](/filings/0000950170-24-050950.md) | [51.4](/filings/0000950170-24-086937.md) | [45.0](/filings/0000950170-24-118320.md) | [44.1](/filings/0001628280-26-008662.md) | [51.7](/filings/0000950170-25-062859.md) | [57.1](/filings/0000354190-25-000011.md) | [55.8](/filings/0001628280-25-050734.md) | [47.3](/filings/0001628280-26-053489.md) | [54.5](/filings/0001628280-26-031592.md) | [58.1](/filings/0001628280-26-053489.md) |
| Long-term debt | $bn | [6.0](/filings/0000950170-23-056014.md) | [7.0](/filings/0000950170-25-021775.md) | [8.0](/filings/0000950170-24-050950.md) | [7.8](/filings/0000950170-24-086937.md) | [7.8](/filings/0000950170-24-118320.md) | [12.7](/filings/0001628280-26-008662.md) | [12.4](/filings/0000950170-25-062859.md) | [12.1](/filings/0000354190-25-000011.md) | [12.1](/filings/0001628280-25-050734.md) | [12.1](/filings/0001628280-26-053489.md) | [12.1](/filings/0001628280-26-031592.md) | [12.0](/filings/0001628280-26-053489.md) |
| Short-term borrowings | $bn | [0.4](/filings/0000950170-23-056014.md) | [0.7](/filings/0000950170-25-021775.md) | [0.1](/filings/0000950170-24-050950.md) | [0.3](/filings/0000950170-24-086937.md) | [0.2](/filings/0000950170-24-118320.md) | [0.2](/filings/0001628280-26-008662.md) | [0.5](/filings/0000950170-25-062859.md) | [0.6](/filings/0000354190-25-000011.md) | [0.8](/filings/0001628280-25-050734.md) | [0.6](/filings/0001628280-26-053489.md) | [0.6](/filings/0001628280-26-031592.md) | [1.5](/filings/0001628280-26-053489.md) |
| Shareholders' equity | $bn | [10.5](/filings/0000950170-23-056014.md) | [10.8](/filings/0000950170-25-021775.md) | [11.3](/filings/0000950170-24-050950.md) | [11.6](/filings/0000950170-24-086937.md) | [12.2](/filings/0000950170-24-118320.md) | [20.2](/filings/0001628280-26-008662.md) | [22.3](/filings/0000950170-25-062859.md) | [23.0](/filings/0000354190-25-000011.md) | [23.2](/filings/0001628280-25-050734.md) | [23.3](/filings/0001628280-26-053489.md) | [23.8](/filings/0001628280-26-031592.md) | [23.7](/filings/0001628280-26-053489.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [897 d](/filings/0000950170-24-118320.md) | [694 d](/filings/0001628280-26-008662.md) | [789](/filings/0000950170-25-062859.md) | [120 d](/filings/0000354190-25-000011.md) | [935 d](/filings/0001628280-25-050734.md) | [739 d](/filings/0001628280-26-008662.md) | [872](/filings/0001628280-26-031592.md) | [(424) d](/filings/0001628280-26-053489.md) | [729 d](/filings/0001628280-25-050734.md) | [753 d](/filings/0001628280-26-008662.md) | [957](/filings/0001628280-26-031592.md) | [10.0 d](/filings/0001628280-26-053489.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [119 d](/filings/0000950170-24-118320.md) | [120 d](/filings/0001628280-26-008662.md) | [131](/filings/0000950170-25-062859.md) | [131 d](/filings/0000354190-25-000011.md) | [132 d](/filings/0001628280-25-050734.md) | [131 d](/filings/0001628280-26-008662.md) | [166](/filings/0001628280-26-031592.md) | [167 d](/filings/0001628280-26-053489.md) | [167 d](/filings/0001628280-25-050734.md) | [168 d](/filings/0001628280-26-008662.md) | [180](/filings/0001628280-26-031592.md) | [179 d](/filings/0001628280-26-053489.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-031592.md) | [0.0 d](/filings/0001628280-26-053489.md) | not reported | not reported | [310](/filings/0001628280-26-031592.md) | [170 d](/filings/0001628280-26-053489.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 256,300,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053489.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.